Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-15

Clinical Trial Update: INTREPId (INTermediate Risk Erection PreservatIon Trial) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (INTREPId) for prostate cancer, focused on erection preservation, is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING